Cannabis and psychosis: understanding the smoke signals

Affiliations

¹ The Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario Canada; Icahn School of Medicine at Mount Sinai, New York, NY 10070, USA. Electronic address: rachel.rabin@camh.ca.
² Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario Canada; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario Canada.

Free article

Comment

Rachel A Rabin et al. Lancet Psychiatry. 2016 Oct.

Free article

. 2016 Oct;3(10):909-910.

doi: 10.1016/S2215-0366(16)30230-9. Epub 2016 Aug 23.

¹ The Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario Canada; Icahn School of Medicine at Mount Sinai, New York, NY 10070, USA. Electronic address: rachel.rabin@camh.ca.
² Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario Canada; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario Canada.

No abstract available

Comment on

Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
Schoeler T, Petros N, Di Forti M, Klamerus E, Foglia E, Ajnakina O, Gayer-Anderson C, Colizzi M, Quattrone D, Behlke I, Shetty S, McGuire P, David AS, Murray R, Bhattacharyya S. Schoeler T, et al. Lancet Psychiatry. 2016 Oct;3(10):947-953. doi: 10.1016/S2215-0366(16)30188-2. Epub 2016 Aug 23. Lancet Psychiatry. 2016. PMID: 27567467